Results 221 to 230 of about 391,518 (330)
Czech Managerial Compensations: Why Does it Pay Off to Climb the Corporate Ladder?
Teodora Paligorova
openalex +1 more source
Clinical analysis reveals significant dysregulation of FGFRL1 in esophageal cancer (EC) patients. RNAi‐coupled next‐generation sequencing (NGS) and in vitro study reveal FGFRL1‐mediated EC progression via EMT, PI3K/Akt, and Notch pathways. Functional assays confirm its role in tumor growth, migration, and invasion.
Aprajita Srivastava +3 more
wiley +1 more source
Microstructure-Dependent Creep Mechanisms in Heat-Treated CZ1 Zr Alloy at 380 °C. [PDF]
Shi H +10 more
europepmc +1 more source
The Effect of Relaxation Training on Indoor Sport Climbing Performance of College Students
Robert G. Fraser
openalex +1 more source
We investigated the toxicity of 12 active compounds commonly found in herbal weight loss supplements (WLS) using human liver and colon cell models. Epigallocatechin‐3‐gallate was the only compound showing significant toxicity. Metabolic profiling revealed protein degradation, disrupted energy and lipid metabolism suggesting that the inclusion of EGCG ...
Emily C. Davies +3 more
wiley +1 more source
ADVANCEMENT OF A WALL CLIMBING ROBOT FOR VARIOUS APPLICATIONS
Pawar Mansi Shailendrasingh
openalex +1 more source
KLK7, a tissue kallikrein‐related peptidase, is elevated in advanced colorectal cancer and associated with shorter survival. High KLK7 levels in ascites correlate with peritoneal metastasis. In mice, KLK7 overexpression increases metastasis. In vitro, KLK7 enhances cancer cell proliferation, migration, adhesion, and spheroid formation, driving ...
Yosr Z. Haffani +6 more
wiley +1 more source
Development of Vmax III: Magnetic Wall Climbing Robot with Holonomic and Omni-directional Mobility
Kiyoshi Tsuru, Shigeo Hirose
openalex +2 more sources
NF90–NF45 functions as a negative regulator of methyltransferase‐like 3/14 (METTL3/14)‐mediated N6‐methyladenosine (m6A) modification on primary microRNAs (pri‐miRNAs). NF90–NF45 binds to anti‐oncogenic pri‐miRNAs and inhibits their m6A modification, thereby suppressing the biogenesis of anti‐oncogenic miRNAs.
Takuma Higuchi +6 more
wiley +1 more source

